Cargando…

Clinical classification systems and long-term outcome in mid- and late-stage Parkinson’s disease

Parkinson’s disease shows a heterogeneous course and different clinical subtyping systems have been described. To compare the capabilities of two clinical classification systems, motor-phenotypes, and a simplified clinical motor-nonmotor subtyping system, a cohort was included at mean 7.9 ± 5.3 year...

Descripción completa

Detalles Bibliográficos
Autores principales: Ygland Rödström, Emil, Puschmann, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329298/
https://www.ncbi.nlm.nih.gov/pubmed/34341343
http://dx.doi.org/10.1038/s41531-021-00208-4
_version_ 1783732468348616704
author Ygland Rödström, Emil
Puschmann, Andreas
author_facet Ygland Rödström, Emil
Puschmann, Andreas
author_sort Ygland Rödström, Emil
collection PubMed
description Parkinson’s disease shows a heterogeneous course and different clinical subtyping systems have been described. To compare the capabilities of two clinical classification systems, motor-phenotypes, and a simplified clinical motor-nonmotor subtyping system, a cohort was included at mean 7.9 ± 5.3 years of disease duration, classified using both clinical systems, and reexamined and reclassified at the end of an observation period. Time-points were retrospectively extracted for five major disease milestones: death, dementia, Hoehn and Yahr stage 5, nursing home living, and walking aid use. Eighty-nine patients were observed for 8.1 ± 2.7 years after inclusion. Dementia developed in 32.9% of the patients and 36.0–67.4% reached the other milestones. Motor-phenotypes were unable to stratify risks during this period, but the worst compared with the more favorable groups in the motor-nonmotor system conveyed hazard ratios between 2.6 and 63.6 for all milestones. A clear separation of risks for dying, living at the nursing home, and reaching motor end-stage was also shown when using only postural instability and gait disorder symptoms, without weighing them against the severity of the tremor. At reexamination, 29.4% and 64.7% of patients had changed classification groups in the motor-phenotype and motor-nonmotor systems, respectively. The motor-nonmotor system thus stratified risks of reaching crucial outcomes in mid–late Parkinson’s disease far better than the well-studied motor-phenotypes. Removing the tremor aspect of motor-phenotypes clearly improved this system, however. Classifications in both systems became unstable over time. The simplification of the motor-nonmotor system was easily applicable and showed potential as a prognostic marker during a large part of Parkinson’s disease.
format Online
Article
Text
id pubmed-8329298
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-83292982021-08-03 Clinical classification systems and long-term outcome in mid- and late-stage Parkinson’s disease Ygland Rödström, Emil Puschmann, Andreas NPJ Parkinsons Dis Article Parkinson’s disease shows a heterogeneous course and different clinical subtyping systems have been described. To compare the capabilities of two clinical classification systems, motor-phenotypes, and a simplified clinical motor-nonmotor subtyping system, a cohort was included at mean 7.9 ± 5.3 years of disease duration, classified using both clinical systems, and reexamined and reclassified at the end of an observation period. Time-points were retrospectively extracted for five major disease milestones: death, dementia, Hoehn and Yahr stage 5, nursing home living, and walking aid use. Eighty-nine patients were observed for 8.1 ± 2.7 years after inclusion. Dementia developed in 32.9% of the patients and 36.0–67.4% reached the other milestones. Motor-phenotypes were unable to stratify risks during this period, but the worst compared with the more favorable groups in the motor-nonmotor system conveyed hazard ratios between 2.6 and 63.6 for all milestones. A clear separation of risks for dying, living at the nursing home, and reaching motor end-stage was also shown when using only postural instability and gait disorder symptoms, without weighing them against the severity of the tremor. At reexamination, 29.4% and 64.7% of patients had changed classification groups in the motor-phenotype and motor-nonmotor systems, respectively. The motor-nonmotor system thus stratified risks of reaching crucial outcomes in mid–late Parkinson’s disease far better than the well-studied motor-phenotypes. Removing the tremor aspect of motor-phenotypes clearly improved this system, however. Classifications in both systems became unstable over time. The simplification of the motor-nonmotor system was easily applicable and showed potential as a prognostic marker during a large part of Parkinson’s disease. Nature Publishing Group UK 2021-08-02 /pmc/articles/PMC8329298/ /pubmed/34341343 http://dx.doi.org/10.1038/s41531-021-00208-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Ygland Rödström, Emil
Puschmann, Andreas
Clinical classification systems and long-term outcome in mid- and late-stage Parkinson’s disease
title Clinical classification systems and long-term outcome in mid- and late-stage Parkinson’s disease
title_full Clinical classification systems and long-term outcome in mid- and late-stage Parkinson’s disease
title_fullStr Clinical classification systems and long-term outcome in mid- and late-stage Parkinson’s disease
title_full_unstemmed Clinical classification systems and long-term outcome in mid- and late-stage Parkinson’s disease
title_short Clinical classification systems and long-term outcome in mid- and late-stage Parkinson’s disease
title_sort clinical classification systems and long-term outcome in mid- and late-stage parkinson’s disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329298/
https://www.ncbi.nlm.nih.gov/pubmed/34341343
http://dx.doi.org/10.1038/s41531-021-00208-4
work_keys_str_mv AT yglandrodstromemil clinicalclassificationsystemsandlongtermoutcomeinmidandlatestageparkinsonsdisease
AT puschmannandreas clinicalclassificationsystemsandlongtermoutcomeinmidandlatestageparkinsonsdisease